Question to the Department of Health and Social Care:

To ask the Secretary of State for Health, how many people who were infected with hepatitis C due to contaminated blood products supplied by the NHS have attained sustained virological response following treatment for the infection.

Information on the numbers of people with hepatitis C through NHS-supplied blood or blood products who have attained sustained virological response following treatment for the infection is not held centrally. NHS England’s commissioning policy is for the treatment of patients based on clinical need, not on the route of infection.

All patients who meet the policy criteria, including those infected through NHS-supplied blood or blood products, are eligible for the new hepatitis C treatments. This will be dependent upon the individual patient’s hepatitis C genotype and cirrhosis status.